DrugPatentWatch Database Preview
Profile for Australia Patent: 2006276205
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Australia Patent: 2006276205
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Feb 23, 2029 | Novartis | TASIGNA | nilotinib hydrochloride |
Start Trial | Jan 18, 2027 | Novartis | TASIGNA | nilotinib hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |